Year-end Sale % OFF 
Abstract
The recent publication of the results of a relatively large cohort of patients treated with stereotactic body radiation therapy (SBRT) at the Mayo Clinic for oligometastatic prostate cancer (1) has to be considered as another significant step toward the assessment of the potential of radiation therapy in the optimal management of these “niche” patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
